Quantcast
Last updated on April 18, 2014 at 1:21 EDT

Latest Sjögren's syndrome Stories

2013-04-04 11:41:15

Hormonal changes could precede development of the condition, say authors Low testosterone levels may herald the subsequent development of rheumatoid arthritis in men, suggests research published online in the Annals of the Rheumatic Diseases. Sex hormones are thought to play a part in the development of rheumatoid arthritis, and both men and women with the condition tend to have lower levels of testosterone in their blood than healthy people. But it is not clear whether this is a...

2013-04-01 16:24:07

Immune Deficiency Foundation (IDF) Plans Series of Activities to Educate Public and Get Patients with Primary Immunodeficiency Diseases the Resources They Need TOWSON, Md., April 1, 2013 /PRNewswire/ -- Approximately 250,000 people are diagnosed with primary immunodeficiency diseases in the United States, but thousands more go undetected and untreated. These diseases are chronic illnesses caused by hereditary or genetic defects in the immune system in which part of the body's...

2013-03-25 08:27:52

Lead product, lifitegrast ophthalmic solution for the treatment of dry eye, will expand Shire's presence in ophthalmology BRISBANE, Calif., March 25, 2013 /PRNewswire/ -- SARcode Bioscience, Inc., an ophthalmic biopharmaceutical company, announced today that it will be acquired by Shire US Holdings Inc., a global specialty biopharmaceutical company focused on enabling people with life-altering conditions to lead better lives. SARcode's lead program, lifitegrast ophthalmic solution,...

2013-03-25 08:27:10

Acquisition brings Shire a new phase 3 compound being investigated for the signs and symptoms of Dry Eye Disease LEXINGTON, Massachusetts, March 25, 2013 /PRNewswire/ -- Shire plc (LSE: SHP, NASDAQ: SHPG) today announced that it will acquire SARcode Bioscience Inc., a privately held biopharmaceutical company based in Brisbane, California. This acquisition continues to build Shire's presence in the ophthalmology therapeutic category and brings a new phase 3 compound -...

2013-03-07 23:51:30

26 countries can't afford certain disease modifying drugs, so excluding 320 million people This means that 320 million people - 40% of Europe's population - who could benefit from treatment with disease modifying drugs (DMARDs) would struggle to get access to them, say the researchers. DMARDs are extremely effective for the treatment of rheumatoid arthritis, and the European League Against Rheumatism (EULAR) recommends the use of synthetic DMARDs immediately after diagnosis to halt...

2013-02-09 23:01:26

Bel Marra Health, who offers high-quality, specially formulated vitamins and nutritional supplements, is reporting on a new study that explains how a new saliva test is making breakthroughs in Parkinson´s disease. Toronto, ON (PRWEB) February 09, 2013 Bel Marra Health, who offers high-quality, specially formulated vitamins and nutritional supplements, is reporting on a new study that explains how a new saliva test is making breakthroughs in Parkinson´s disease. As Bel Marra...

2013-01-29 23:02:52

Salimetrics will present two Spit Camp Workshops as part of the 2013 SRCD Preconference on April 17th, 2013. These enhanced workshops will be presented by Douglas Granger, PhD, Director of the Center for Interdisciplinary Salivary Bioscience Research at the Johns Hopkins University School of Nursing, and educate attendees on the basics of incorporating salivary analytes into their research. (PRWEB) January 29, 2013 Researchers attending the 2013 SRCD biennial meeting or in the Seattle,...

2013-01-14 16:23:16

SAN DIEGO, Jan. 14, 2013 /PRNewswire-USNewswire/ -- New research suggests that testing a portion of a person's saliva gland may be a way to diagnose Parkinson's disease. The study will be presented at the American Academy of Neurology's 65th Annual Meeting in San Diego, March 16 to 23, 2013. "There is currently no diagnostic test for Parkinson's disease," said study author Charles Adler, MD, PhD, with the Mayo Clinic Arizona and a Fellow of the American Academy of Neurology. "We have...

Saliva Could Hold Clues To Parkinson's Detection
2013-01-11 10:58:59

redOrbit Staff & Wire Reports - Your Universe Online The search for a diagnostic test for Parkinson´s disease may soon be over, as new research suggests that testing part of a patient´s saliva gland could detect the degenerative disorder. As part of a study released Thursday, Charles Adler of the Mayo Clinic in Arizona and colleagues recruited 15 Parkinson´s patients with an average age of 68. The study participants had dealt with the disease for an average of 12...

2013-01-10 16:23:10

WASHINGTON, Jan. 10, 2013 /PRNewswire/ -- The Immune Deficiency Foundation (IDF), the national patient organization dedicated to improving the lives of persons with primary immunodeficiency diseases (PIDD), is proud to announce that the Medicare IVIG Access Act (HR 1845) was signed into law today, January 10, 2013, by President Obama. HR 1845 provides for a demonstration project to examine the benefits of providing coverage and payment for items and services necessary to administer...